Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FK199B (Zolpidem MR Tablet) Phase III Clinical Study -A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia -

NCT00283946 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00283946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00283946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FK199B (Zolpidem MR Tablet) Phase III Clinical Study -A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia -
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
November 30, 2007
Enrollment
876 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

sleep disorders, sleep initiation and maintenance disorders